Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 4/20 | 0.67 |
| ▸ | BCR | P11274 | 4/20 | 0.67 |
| ▸ | SRC | P12931 | 4/20 | 0.67 |
| ▸ | PRKCA | P17252 | 2/20 | 0.66 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.66 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.66 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.66 |
| ▸ | IKBKB | O14920 | 2/20 | 0.64 |
| ▸ | EGFR | P00533 | 2/20 | 0.61 |
| ▸ | PRKACA | P17612 | 1/20 | 0.61 |
| ▸ | PRKACG | P22612 | 1/20 | 0.61 |
| ▸ | PRKACB | P22694 | 1/20 | 0.61 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.61 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.55 |
| ▸ | JAK2 | O60674 | 3/20 | 0.53 |
| ▸ | PLK1 | P53350 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4902560 | 0.92 | ABL1 (0.72) | ABL1BCRSRCPRKCAPRKCD | |
| SCHEMBL4903199 | 0.88 | IKBKB (0.64) | ABL1BCRSRCPRKCAPRKCD | |
| SCHEMBL4902199 | 0.85 | ABL1 (0.63) | ABL1BCRSRCPRKCAPRKCD | |
| SCHEMBL7463426 | 0.83 | ABL1 (0.80) | ABL1BCRSRCPRKCAPRKCD | |
| SCHEMBL4905227 | 0.83 | ABL1 (0.70) | ABL1BCRSRCPRKCAPRKCD | |
| SCHEMBL2944432 | 0.82 | ABL1 (0.82) | ABL1BCRSRCIKBKBEGFR | |
| SCHEMBL7462511 | 0.81 | IKBKB (0.64) | ABL1BCRSRCPRKCAPRKCD | |
| SCHEMBL1789 | 0.81 | ABL1 (1.00) | ABL1BCRSRCPRKCAPRKCD | |
| SCHEMBL4893357 | 0.81 | ABL1 (0.61) | ABL1BCRSRCPRKCAPRKCD | |
| SCHEMBL4386919 | 0.80 | ABL1 (0.82) | ABL1BCRSRCPRKCAPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080187575-A1 | Pyrimidine Derivatives | VICHEM CHEMIE KFT (HU) | 2008-08-07 | — | — | US | claimed |
| EP-1786781-A2 | PYRIMIDINE DERIVATIVES | GPC Biotech AG (DE) | 2007-05-23 | — | — | EP | claimed |
| WO-2006021458-A2 | PYRIMIDINE DERIVATIVES | GPC BIOTECH AG (DE) | 2006-03-02 | — | — | WO | claimed |
| US-20080187575-A1 | Pyrimidine Derivatives | VICHEM CHEMIE KFT (HU) | 2008-08-07 | — | — | US | disclosed |
| EP-1786781-A2 | PYRIMIDINE DERIVATIVES | GPC Biotech AG (DE) | 2007-05-23 | — | — | EP | disclosed |
| WO-2006021458-A2 | PYRIMIDINE DERIVATIVES | GPC BIOTECH AG (DE) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080187575-A1 | Pyrimidine Derivatives | TYMP, TDP1, PNP | ABL1 2843/4885BCR 2315/4885SRC 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.